Avidity Biosciences (RNA) Return on Equity (2020 - 2025)
Historic Return on Equity for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to 0.36%.
- Avidity Biosciences' Return on Equity fell 1500.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.33% for FY2024, which is 600.0% up from last year.
- Per Avidity Biosciences' latest filing, its Return on Equity stood at 0.36% for Q3 2025, which was down 1500.0% from 0.36% recorded in Q2 2025.
- Over the past 5 years, Avidity Biosciences' Return on Equity peaked at 0.21% during Q3 2024, and registered a low of 0.43% during Q3 2022.
- Over the past 5 years, Avidity Biosciences' median Return on Equity value was 0.34% (recorded in 2022), while the average stood at 0.32%.
- As far as peak fluctuations go, Avidity Biosciences' Return on Equity tumbled by -1700bps in 2021, and later surged by 2000bps in 2024.
- Quarter analysis of 5 years shows Avidity Biosciences' Return on Equity stood at 0.3% in 2021, then fell by -20bps to 0.36% in 2022, then decreased by -14bps to 0.42% in 2023, then soared by 47bps to 0.22% in 2024, then plummeted by -62bps to 0.36% in 2025.
- Its Return on Equity stands at 0.36% for Q3 2025, versus 0.36% for Q2 2025 and 0.27% for Q1 2025.